TG

TG Therapeutics

- NASDAQ:TGTX
Last Updated 2024-04-23
  • TG Therapeutics, a biopharmaceutical company, develops agents for the treatment of hematologic malignancies and autoimmune disorders.

  • Locations

    • New York NY

  • Total Funding (USD)

    25.0 million

  • Industries

    Real Estate, Mobile Apps, Cyber Security

  • Security

    Type: ORD
    CUSIP: 88322Q108
    ISIN: US88322Q1085
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.

Request Demo